🇺🇸 FDA
Pipeline program

Venetoclax, Venetoclax, Matching Placebo for Venetoclax, Venetoclax, AZACITIDINE

M15-656

Phase 3 small_molecule active

Quick answer

Venetoclax, Venetoclax, Matching Placebo for Venetoclax, Venetoclax, AZACITIDINE for Acute Myeloid Leukemia is a Phase 3 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).

Program details

Company
AbbVie Deutschland GmbH & Co. KG
Indication
Acute Myeloid Leukemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials